PUBLISHER: QYResearch | PRODUCT CODE: 1866702
PUBLISHER: QYResearch | PRODUCT CODE: 1866702
The global market for Syringe was estimated to be worth US$ 10335 million in 2024 and is forecast to a readjusted size of US$ 13179 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
A syringe is a medical device used for administering drugs or extracting body fluids, widely applied in vaccination, drug infusion, clinical blood sampling, and laboratory operations. Standard syringes consist of a needle, barrel, plunger, and safety protection mechanisms, emphasizing sterility, single-use, and ease of operation to minimize infection and cross-contamination risks. As healthcare services extend to primary care and community settings, innovative products such as prefilled syringes, auto-retractable syringes, and micro-injection devices are increasingly adopted, balancing safety, patient comfort, and precise dosage control. Leading manufacturers globally optimize costs through smart manufacturing and large-scale operations, while adhering to ISO, FDA, and national medical device regulations, ensuring product reliability and compliance in high-intensity usage scenarios. Technological upgrades and product iterations in the syringe industry directly support vaccination, chronic disease management, and in vitro diagnostics, underpinning rapid market expansion and providing foundational support to global healthcare systems.In 2024, global syringe production reached approximately 84.12 billion units, with an average global market price of around US$ 122.9 per k unit.
The global syringe market is driven by rising vaccination volumes, expanding chronic disease management needs, and public healthcare system development. COVID-19 vaccination campaigns and seasonal influenza vaccination programs have created long-term, inelastic demand through government procurement and public health initiatives, stimulating capacity expansion and technological innovation. The growing chronic disease patient population, particularly for diabetes, anticoagulation, and biologic drug injections, provides market opportunities for prefilled and smart syringes. Leading international and domestic manufacturers leverage automated production, precision molding, and intelligent inspection to enhance product consistency and safety while reducing unit costs and strengthening competitiveness. Policy support for primary care, telemedicine, and home healthcare further promotes syringe penetration in community and home settings. Global supply chain integration and increasing OEM/ODM collaborations support cross-regional market expansion and capital growth, establishing long-term growth momentum.Despite strong demand, the syringe industry faces multiple challenges. Regulatory compliance is increasingly stringent, requiring substantial investment to meet FDA, CE, and ISO certifications, raising operational costs. The industry is highly fragmented, with intense price competition in the low-end market limiting profit margins, forcing companies to rely on technological innovation and brand building for differentiation. Raw material price volatility, rising logistics costs, and international trade uncertainties increase supply chain risk, particularly during peak vaccination periods and public health emergencies, requiring effective production continuity and inventory management. Additionally, tightening environmental regulations regarding plastic syringe disposal and recycling increase long-term operational costs and risk management challenges.Downstream syringe demand is becoming more diversified, personalized, and high-end. Traditional hospitals and laboratories remain core markets, but rapid growth in home self-management, community healthcare, and telemedicine services is driving adoption of prefilled, micro, and smart syringes. Continuous vaccination campaigns, normalized chronic disease injections, and expansion of in vitro diagnostics jointly support long-term stable demand. Healthcare digitalization integrates syringes with wearable devices, remote monitoring systems, and cloud-based data platforms, enabling closed-loop management and precise dose tracking, improving patient experience and safety. Companies are gradually transforming from single consumable suppliers to comprehensive injection solution providers, unlocking new incremental markets and long-term commercial value.
This report aims to provide a comprehensive presentation of the global market for Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Syringe by region & country, by Type, and by Application.
The Syringe market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Syringe.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.